Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Modern Chinese Medicine Group Co. Ltd. ( (HK:1643) ).
Modern Chinese Medicine Group Co. Ltd. has clarified details of its share option scheme in relation to its 2024 annual report, confirming that up to 60 million shares, equivalent to 10% of its issued share capital as at the report date, are available for issuance under the scheme and any other share schemes combined. The share option scheme, which became effective in January 2021 before updated listing rule requirements took effect, allows options to be exercised for up to 10 years and gives the board discretion to impose vesting periods on a case-by-case basis; to date, no options have been granted, meaning the full 60 million-share mandate remains available, potentially providing the company with future flexibility in employee incentives and capital management without any immediate dilution for existing shareholders.
The most recent analyst rating on (HK:1643) stock is a Hold with a HK$0.67 price target. To see the full list of analyst forecasts on Modern Chinese Medicine Group Co. Ltd. stock, see the HK:1643 Stock Forecast page.
More about Modern Chinese Medicine Group Co. Ltd.
Modern Chinese Medicine Group Co., Ltd. is a Hong Kong-listed company engaged in the traditional Chinese medicine sector, with its shares traded on the Main Board of the Stock Exchange of Hong Kong under stock code 1643. The group operates through a board comprising three executive directors and three independent non-executive directors, reflecting a conventional governance structure for a mid-sized listed healthcare enterprise.
Average Trading Volume: 508,033
Technical Sentiment Signal: Hold
Current Market Cap: HK$381.6M
For an in-depth examination of 1643 stock, go to TipRanks’ Overview page.